CV Sciences, Inc. Positioned to Participate in the Medicare and Medicaid Pilot Program for CBD
Private Wellness Club Continuum Unlocks Final Membership Tier at West Village Flagship
Ginkgo Bioworks Partners with Carnegie-Mellon University to Develop Innovative New Cancer Screening Approach
KLAS Report Shows Strong Early Results for TrustCommerce Cloud Payments
BioFlorida Announces Appointment of Dr. Anthony Japour, CEO of iTolerance, Inc., as Chair of the Southeast Chapter
KING OF PRUSSIA, PA / ACCESSWIRE / November 19, 2019 / Chronic Kidney Disease (CKD) is a world-wide affliction. Many...
Experienced executive will accelerate company’s growth in quickly developing market SALT LAKE CITY--(BUSINESS WIRE)--Clinical Innovations, one of the world’s largest...
NANAIMO, BC / ACCESSWIRE / November 18, 2019 / The Denturist Association of BC (DABC) is demanding that the government...
REDWOOD CITY, Calif.--(BUSINESS WIRE)--InterVenn Biosciences, a company in the life sciences and technology sector, is pleased to announce that the...
NEW YORK, NY / ACCESSWIRE / November 18, 2019 / Kadmon Holdings, Inc. (NYSE:KDMN) today announced the closing of its...
TORONTO, ON / ACCESSWIRE / November 18, 2019 / Intellipharmaceutics International Inc. (OTCQB:IPCIF and TSX:IPCI) ("Intellipharmaceutics" or the "Company") and...
HERZELIYA, ISRAEL and CALGARY, ALBERTA / ACCESSWIRE / November 18, 2019 / InnoCan Pharma Corporation ("InnoCan" or the "Company") (CSE:INNO)...
MINNEAPOLIS--(BUSINESS WIRE)--#Healthcare--In a move that reflects Medical Alley’s position as the global epicenter of health innovation and care, the Medical...
Collective partners with Kno2 to enable physician and care team members with high-value clinical insights at the point of care...
BAD HOMBURG, GERMANY – The first patients are about to be enrolled in the EuroPN survey, a clinical study that...
LOS ANGELES, CA / ACCESSWIRE / November 18, 2019 / International Cannabrands Inc. (CSE:INCB) (the "Company") is pleased to announce...
The fear that dental professionals may be replaced by robots is as real as the excitement of wondering what the...
Operational Update LONDON, UK / ACCESSWIRE / November 18, 2019 / Hemogenyx Pharmaceuticals plc (LSE:HEMO), the biopharmaceutical group developing new...
— Study results reflect advancements in HER2-positive, triple-negative, and hormone receptor-positive breast cancer — — Follow-up data from pivotal Phase...
PLANEGG/MUNICH, GERMANY and BOSTON MA / ACCESSWIRE / November 15, 2019 / MorphoSys (FSE: MOR; Prime Standard Segment; MDAX & TecDAX;...
Organizational decision-makers continue to make remarkable progress in leveraging technology to improve operations as well as patient treatment outcomes. Long...
This press release replaces the press release issued 11/15/2019 at 6:30 a.m., which included an incorrect date. The company had...
BURLINGAME, CA / ACCESSWIRE / November 15, 2019 / Humanigen, Inc., (OTCQB:HGEN) ("Humanigen"), a clinical stage biopharmaceutical company focused on...
Successfully building BioPharma pipeline in high-value indications Company plans to advance IND-cleared program into a Phase 1 study in a...
Reported Positive Phase 2 Interim Data in Advanced Non-Small Cell Lung Cancer Patients MORRISVILLE, NC / ACCESSWIRE / November 15,...
